메뉴 건너뛰기




Volumn 98, Issue 12, 2009, Pages 4928-4940

Differential involvement of P-glycoprotein (ABCB1) in permeability, tissue distribution, and antinociceptive activity of methadone, buprenorphine, and diprenorphine: In vitro and in vivo evaluation

Author keywords

ADME; Distribution; P glycoprotein; Pharamcokinetics; Pharmacodynamics; Transporters

Indexed keywords

BUPRENORPHINE; DIPRENORPHINE; ELACRIDAR; METHADONE; MULTIDRUG RESISTANCE PROTEIN 1; VERAPAMIL;

EID: 71649104335     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21770     Document Type: Article
Times cited : (83)

References (50)
  • 2
    • 0033756459 scopus 로고    scopus 로고
    • Transporter-mediated permeation of drugs across the blood-brain barrier
    • DOI 10.1002/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D
    • Tamai I, Tsuji A. 2000. Transporter-mediated permeation of drugs across the blood-brain barrier. J Pharm Sci 89:1371-1388. (Pubitemid 30805244)
    • (2000) Journal of Pharmaceutical Sciences , vol.89 , Issue.11 , pp. 1371-1388
    • Tamai, I.1    Tsuji, A.2
  • 4
    • 0028825399 scopus 로고
    • Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A
    • Schinkel AH, Wagenaar E, van Deemter L, Mol CA, Borst P. 1995. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 96:1698-1705.
    • (1995) J Clin Invest , vol.96 , pp. 1698-1705
    • Schinkel, A.H.1    Wagenaar, E.2    Van Deemter, L.3    Mol, C.A.4    Borst, P.5
  • 6
    • 0041837255 scopus 로고    scopus 로고
    • Blood-brain barrier efflux transport
    • Golden PL, Pollack GM. 2003. Blood-brain barrier efflux transport. J Pharm Sci 92:1739-1753.
    • (2003) J Pharm Sci , vol.92 , pp. 1739-1753
    • Golden, P.L.1    Pollack, G.M.2
  • 7
    • 21344446092 scopus 로고    scopus 로고
    • The impact of pharmacologic and genetic knockout of P-glycoprotein on nelfinavir levels in the brain and other tissues in mice
    • DOI 10.1002/jps.20344
    • Salama NN, Kelly EJ, Bui T, Ho RJ. 2005. The impact of pharmacologic and genetic knockout of P-glycoprotein on nelfinavir levels in the brain and other tissues in mice. J Pharm Sci 94:1216-1225. (Pubitemid 40904186)
    • (2005) Journal of Pharmaceutical Sciences , vol.94 , Issue.6 , pp. 1216-1225
    • Salama, N.N.1    Kelly, E.J.2    Bui, T.3    Ho, R.J.Y.4
  • 8
    • 0037229942 scopus 로고    scopus 로고
    • Role of P-glycoprotein in pharmacokinetics: Clinical implications
    • DOI 10.2165/00003088-200342010-00003
    • Lin JH, Yamazaki M. 2003. Role of P-glycoprotein in pharmacokinetics: Clinical implications. Clin Pharmacokinet 42:59-98. (Pubitemid 36092258)
    • (2003) Clinical Pharmacokinetics , vol.42 , Issue.1 , pp. 59-98
    • Lin, J.H.1    Yamazaki, M.2
  • 9
    • 1642579542 scopus 로고    scopus 로고
    • Variable modulation of opioid brain uptake by P-glycoprotein in mice
    • DOI 10.1016/j.bcp.2003.08.027
    • Dagenais C, Graff CL, Pollack GM. 2004. Variable modulation of opioid brain uptake by P-glycoprotein in mice. Biochem Pharmacol 67:269-276. (Pubitemid 38112757)
    • (2004) Biochemical Pharmacology , vol.67 , Issue.2 , pp. 269-276
    • Dagenais, C.1    Graff, C.L.2    Pollack, G.M.3
  • 10
    • 34748829961 scopus 로고    scopus 로고
    • Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel's tissue distribution in sprague dawley rats
    • DOI 10.1002/jps.20893
    • Hassan HE, Myers AL, Lee IJ, Coop A, Eddington ND. 2007. Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel's tissue distribution in Sprague Dawley rats. J Pharm Sci 96:2494-2506. (Pubitemid 47477902)
    • (2007) Journal of Pharmaceutical Sciences , vol.96 , Issue.9 , pp. 2494-2506
    • Hassan, H.E.1    Myers, A.L.2    Lee, I.J.3    Coop, A.4    Eddington, N.D.5
  • 11
    • 0037457793 scopus 로고    scopus 로고
    • Drug-drug interaction mediated by inhibition and induction of P-glycoprotein
    • DOI 10.1016/S0169-409X(02)00171-0, PII S0169409X02001710
    • Lin JH. 2003. Drug-drug interaction mediated by inhibition and induction of P-glycoprotein. Adv Drug Deliv Rev 55:53-81. (Pubitemid 36082882)
    • (2003) Advanced Drug Delivery Reviews , vol.55 , Issue.1 , pp. 53-81
    • Lin, J.H.1
  • 12
    • 0027285344 scopus 로고
    • Dose-ranging study of oxycodone for chronic pain in advanced cancer
    • Glare PA, Walsh TD. 1993. Dose-ranging study of oxycodone for chronic pain in advanced cancer. J Clin Oncol 11:973-978.
    • (1993) J Clin Oncol , vol.11 , pp. 973-978
    • Glare, P.A.1    Walsh, T.D.2
  • 13
    • 0036224193 scopus 로고    scopus 로고
    • Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers
    • Murthy BR, Pollack GM, Brouwer KL. 2002. Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers. J Clin Pharmacol 42:569-576.
    • (2002) J Clin Pharmacol , vol.42 , pp. 569-576
    • Murthy, B.R.1    Pollack, G.M.2    Brouwer, K.L.3
  • 16
    • 0033060742 scopus 로고    scopus 로고
    • Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat
    • Letrent SP, Pollack GM, Brouwer KR, Brouwer KL. 1999. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat. Drug Metab Dispos 27:827-834.
    • (1999) Drug Metab Dispos , vol.27 , pp. 827-834
    • Letrent, S.P.1    Pollack, G.M.2    Brouwer, K.R.3    Brouwer, K.L.4
  • 17
    • 0031946026 scopus 로고    scopus 로고
    • Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat
    • Letrent SP, Pollack GM, Brouwer KR, Brouwer KL. 1998. Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat. Pharm Res 15:599-605.
    • (1998) Pharm Res , vol.15 , pp. 599-605
    • Letrent, S.P.1    Pollack, G.M.2    Brouwer, K.R.3    Brouwer, K.L.4
  • 18
    • 33846902630 scopus 로고    scopus 로고
    • Opioids and efflux transporters. Part 1: P-Glycoprotein substrate activity of N-substituted analogs of meperidine
    • Mercer SL, Hassan HE, Cunningham CW, Eddington ND, Coop A. 2007. Opioids and efflux transporters. Part 1: P-Glycoprotein substrate activity of N-substituted analogs of meperidine. Bioorg Med Chem Lett 17:1160-1162.
    • (2007) Bioorg Med Chem Lett , vol.17 , pp. 1160-1162
    • Mercer, S.L.1    Hassan, H.E.2    Cunningham, C.W.3    Eddington, N.D.4    Coop, A.5
  • 19
    • 0036143616 scopus 로고    scopus 로고
    • Interaction of nonpeptidic delta agonists with P-glycoprotein by in situ mouse brain perfusion: Liquid chromatography-mass spectrometry analysis and internal standard strategy
    • DOI 10.1002/jps.1175
    • Dagenais C, Ducharme J, Pollack GM. 2002. Interaction of nonpeptidic delta agonists with P-glycoprotein by in situ mouse brain perfusion: Liquid chromatography-mass spectrometry analysis and internal standard strategy. J Pharm Sci 91:244-252. (Pubitemid 34074482)
    • (2002) Journal of Pharmaceutical Sciences , vol.91 , Issue.1 , pp. 244-252
    • Dagenais, C.1    Ducharme, J.2    Pollack, G.M.3
  • 20
    • 0033844780 scopus 로고    scopus 로고
    • Morphine antinociception is enhanced in mdr1a gene-deficient mice
    • DOI 10.1023/A:1007546719287
    • Zong J, Pollack GM. 2000. Morphine antinociception is enhanced in mdr1a gene-deficient mice. Pharm Res 17:749-753. (Pubitemid 30670642)
    • (2000) Pharmaceutical Research , vol.17 , Issue.6 , pp. 749-753
    • Zong, J.1    Pollack, G.M.2
  • 21
    • 0034016617 scopus 로고    scopus 로고
    • Opiate-induced analgesia is increased and prolonged in mice lacking P- Glycoprotein
    • Thompson SJ, Koszdin K, Bernards CM. 2000. Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein. Anesthesiology 92:1392-1399. (Pubitemid 30257201)
    • (2000) Anesthesiology , vol.92 , Issue.5 , pp. 1392-1399
    • Thompson, S.J.1    Koszdin, K.2    Bernards, C.M.3
  • 22
    • 33846650369 scopus 로고    scopus 로고
    • Buprenorphine for the treatment of opioid dependence
    • Boothby LA, Doering PL. 2007. Buprenorphine for the treatment of opioid dependence. Am J Health Syst Pharm 64:266-272.
    • (2007) Am J Health Syst Pharm , vol.64 , pp. 266-272
    • Boothby, L.A.1    Doering, P.L.2
  • 23
    • 0036206856 scopus 로고    scopus 로고
    • Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein
    • DOI 10.1097/00000542-200204000-00019
    • Wandel C, Kim R, Wood M, Wood A. 2002. Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein. Anesthesiology 96:913-920. (Pubitemid 34266685)
    • (2002) Anesthesiology , vol.96 , Issue.4 , pp. 913-920
    • Wandel, C.1    Kim, R.2    Wood, M.3    Wood, A.4
  • 24
    • 0027221177 scopus 로고
    • Synthetic and natural opiates interact with P-glycoprotein in multidrug- Resistant cells
    • Callaghan R, Riordan JR. 1993. Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells. J Biol Chem 268:16059-16064. (Pubitemid 23222114)
    • (1993) Journal of Biological Chemistry , vol.268 , Issue.21 , pp. 16059-16064
    • Callaghan, R.1    Riordan, J.R.2
  • 25
    • 0030926727 scopus 로고    scopus 로고
    • Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets
    • Polli JE, Rekhi GS, Augsburger LL, Shah VP. 1997. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J Pharm Sci 86:690-700.
    • (1997) J Pharm Sci , vol.86 , pp. 690-700
    • Polli, J.E.1    Rekhi, G.S.2    Augsburger, L.L.3    Shah, V.P.4
  • 26
    • 14744285705 scopus 로고    scopus 로고
    • Simultaneous determination of buprenorphine and its prodrug, buprenorphine propionate, by high-performance liquid chromatography with fluorescence detection: Application to pharmacokinetic studies in rabbits
    • DOI 10.1016/j.jchromb.2005.01.002, PII S1570023205000152
    • Liu SY, Liu KS, Kuei CH, Tzeng JI, Ho ST, Wang JJ. 2005. Simultaneous determination of buprenorphine and its prodrug, buprenorphine propionate, by high-performance liquid chromatography with fluorescence detection: Application to pharmacokinetic studies in rabbits. J Chromatogr B Analyt Technol Biomed Life Sci 818:233-239. (Pubitemid 40331829)
    • (2005) Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences , vol.818 , Issue.2 , pp. 233-239
    • Liu, S.-Y.1    Liu, K.-S.2    Kuei, C.-H.3    Tzeng, J.-I.4    Ho, S.-T.5    Wang, J.-J.6
  • 27
    • 0000811019 scopus 로고
    • The evaluation of the analgesic action of pethidine hydrochloride (demerol)
    • Woofle G, Macdonald A. 1944. The evaluation of the analgesic action of pethidine hydrochloride (demerol). J Pharmcol Exp Ther 80:300-307.
    • (1944) J Pharmcol Exp Ther , vol.80 , pp. 300-307
    • Woofle, G.1    Macdonald, A.2
  • 28
    • 0033810893 scopus 로고    scopus 로고
    • Incomplete, asymmetric, and route-dependent cross-tolerance between oxycodone and morphine in the Dark Agouti rat
    • Nielsen CK, Ross FB, Smith MT. 2000. Incomplete, asymmetric, and route-dependent cross-tolerance between oxycodone and morphine in the Dark Agouti rat. J Pharmacol Exp Ther 295:91-99.
    • (2000) J Pharmacol Exp Ther , vol.295 , pp. 91-99
    • Nielsen, C.K.1    Ross, F.B.2    Smith, M.T.3
  • 29
    • 0033968760 scopus 로고    scopus 로고
    • Co-administration of sub-antinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced CNS side-effects in rats
    • Ross FB, Wallis SC, Smith MT. 2000. Co-administration of sub-antinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced CNS side-effects in rats. Pain 84:421-428.
    • (2000) Pain , vol.84 , pp. 421-428
    • Ross, F.B.1    Wallis, S.C.2    Smith, M.T.3
  • 31
    • 0030791978 scopus 로고    scopus 로고
    • Structure-activity relationships of P-glycoprotein interacting drugs: Kinetic characterization of their effects on ATPase activity
    • DOI 10.1016/S0925-4439(97)00026-4, PII S0925443997000264
    • Litman T, Zeuthen T, Skovsgaard T, Stein WD. 1997. Structure-activity relationships of P-glycoprotein interacting drugs: Kinetic characterization of their effects on ATPase activity. Biochim Biophys Acta 1361:159-168. (Pubitemid 27362089)
    • (1997) Biochimica et Biophysica Acta - Molecular Basis of Disease , vol.1361 , Issue.2 , pp. 159-168
    • Litman, T.1    Zeuthen, T.2    Skovsgaard, T.3    Stein, W.D.4
  • 33
    • 0033279844 scopus 로고    scopus 로고
    • The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: In vitro studies using the rat everted intestinal sac
    • Bouer R, Barthe L, Philibert C, Tournaire C, Woodley J, Houin G. 1999. The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: In vitro studies using the rat everted intestinal sac. Fundam Clin Pharmacol 13:494-500.
    • (1999) Fundam Clin Pharmacol , vol.13 , pp. 494-500
    • Bouer, R.1    Barthe, L.2    Philibert, C.3    Tournaire, C.4    Woodley, J.5    Houin, G.6
  • 34
    • 0343526837 scopus 로고    scopus 로고
    • Methadone: A review of its pharmacokinetic/pharmacodynamic properties
    • Garrido MJ, Troconiz IF. 1999. Methadone: A review of its pharmacokinetic/pharmacodynamic properties. J Pharmacol Toxicol Methods 42:61-66.
    • (1999) J Pharmacol Toxicol Methods , vol.42 , pp. 61-66
    • Garrido, M.J.1    Troconiz, I.F.2
  • 35
    • 0031455482 scopus 로고    scopus 로고
    • The P-glycoprotein efflux pump: How does it transport drugs?
    • Sharom FJ. 1997. The P-glycoprotein efflux pump: How does it transport drugs? J Membr Biol 160:161-175.
    • (1997) J Membr Biol , vol.160 , pp. 161-175
    • Sharom, F.J.1
  • 36
    • 17544365536 scopus 로고    scopus 로고
    • The role of passive transbilayer drug movement in multidrug resistance and its modulation
    • DOI 10.1074/jbc.271.22.12897
    • Eytan GD, Regev R, Oren G, Assaraf YG. 1996. The role of passive transbilayer drug movement in multidrug resistance and its modulation. J Biol Chem 271:12897-12902. (Pubitemid 26175862)
    • (1996) Journal of Biological Chemistry , vol.271 , Issue.22 , pp. 12897-12902
    • Eytan, G.D.1    Regev, R.2    Oren, G.3    Assaraf, Y.G.4
  • 38
    • 0033526176 scopus 로고    scopus 로고
    • P-Glycoprotein, a gatekeeper in the blood-brain barrier
    • Schinkel AH. 1999. P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev 36:179-194.
    • (1999) Adv Drug Deliv Rev , vol.36 , pp. 179-194
    • Schinkel, A.H.1
  • 39
    • 33750317876 scopus 로고    scopus 로고
    • Role of human placental efflux transporter P-glycoprotein in the transfer of buprenorphine, levo-alpha-acetylmethadol, and paclitaxel
    • Nekhayeva IA, Nanovskaya TN, Hankins GD, Ahmed MS. 2006. Role of human placental efflux transporter P-glycoprotein in the transfer of buprenorphine, levo-alpha-acetylmethadol, and paclitaxel. Am J Perinatol 23:423-430.
    • (2006) Am J Perinatol , vol.23 , pp. 423-430
    • Nekhayeva, I.A.1    Nanovskaya, T.N.2    Hankins, G.D.3    Ahmed, M.S.4
  • 40
    • 34248196921 scopus 로고    scopus 로고
    • P-glycoprotein mediates brain-to-blood efflux transport of buprenorphine across the blood-brain barrier
    • DOI 10.1080/10611860601141606, PII 772691204
    • Suzuki T, Zaima C, Moriki Y, Fukami T, Tomono K. 2007. P-glycoprotein mediates brain-to-blood efflux transport of buprenorphine across the blood-brain barrier. J Drug Target 15:67-74. (Pubitemid 47161333)
    • (2007) Journal of Drug Targeting , vol.15 , Issue.1 , pp. 67-74
    • Suzuki, T.1    Zaima, C.2    Moriki, Y.3    Fukami, T.4    Tomono, K.5
  • 42
    • 0015821183 scopus 로고
    • Opiate agonists and antagonists discriminated by receptor binding in brain
    • Pert CB, Pasternak G, Snyder SH. 1973. Opiate agonists and antagonists discriminated by receptor binding in brain. Science 182:1359-1361.
    • (1973) Science , vol.182 , pp. 1359-1361
    • Pert, C.B.1    Pasternak, G.2    Snyder, S.H.3
  • 43
    • 0022256398 scopus 로고
    • In vivo receptor binding of opioid drugs at the mu site
    • Rosenbaum JS, Holford NH, Sadee W. 1985. In vivo receptor binding of opioid drugs at the mu site. J Pharmacol Exp Ther 233:735-740.
    • (1985) J Pharmacol Exp Ther , vol.233 , pp. 735-740
    • Rosenbaum, J.S.1    Holford, N.H.2    Sadee, W.3
  • 44
    • 0036827956 scopus 로고    scopus 로고
    • Investigation of transport mechanism of pentazocine across the blood-brain barrier using the in situ rat brain perfusion technique
    • DOI 10.1002/jps.10224
    • Suzuki T, Oshimi M, Tomono K, Hanano M, Watanabe J. 2002. Investigation of transport mechanism of pentazocine across the blood-brain barrier using the in situ rat brain perfusion technique. J Pharm Sci 91:2346-2353. (Pubitemid 35231197)
    • (2002) Journal of Pharmaceutical Sciences , vol.91 , Issue.11 , pp. 2346-2353
    • Suzuki, T.1    Oshimi, M.2    Tomono, K.3    Hanano, M.4    Watanabe, J.5
  • 45
    • 0347504918 scopus 로고    scopus 로고
    • Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine
    • DOI 10.1016/j.clpt.2003.08.011
    • Kharasch ED, Hoffer C, Whittington D, Sheffels P. 2003. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine. Clin Pharmacol Ther 74:543-554. (Pubitemid 37521998)
    • (2003) Clinical Pharmacology and Therapeutics , vol.74 , Issue.6 , pp. 543-554
    • Kharasch, E.D.1    Hoffer, C.2    Whittington, D.3    Sheffels, P.4
  • 46
    • 0038637177 scopus 로고    scopus 로고
    • Modulation of P-glycoprotein transport activity in the mouse blood-brain barrier by rifampin
    • DOI 10.1124/jpet.103.049452
    • Zong J, Pollack GM. 2003. Modulation of P-glycoprotein transport activity in the mouse blood-brain barrier by rifampin. J Pharmacol Exp Ther 306:556-562. (Pubitemid 36886154)
    • (2003) Journal of Pharmacology and Experimental Therapeutics , vol.306 , Issue.2 , pp. 556-562
    • Zong, J.1    Pollack, G.M.2
  • 47
    • 0037392850 scopus 로고    scopus 로고
    • Morphine blood-brain barrier transport is influenced by probenecid co-administration
    • DOI 10.1023/A:1023250900462
    • Tunblad K, Jonsson EN, Hammarlund-Udenaes M. 2003. Morphine blood-brain barrier transport is influenced by probenecid co-administration. Pharm Res 20:618-623. (Pubitemid 36438906)
    • (2003) Pharmaceutical Research , vol.20 , Issue.4 , pp. 618-623
    • Tunblad, K.1    Jonsson, E.N.2    Hammarlund-Udenaes, M.3
  • 48
    • 0037023533 scopus 로고    scopus 로고
    • The influence of P-glycoprotein on morphine transport in Caco-2 cells. Comparison with paclitaxel
    • DOI 10.1016/S0014-2999(02)01366-3, PII S0014299902013663
    • Crowe A. 2002. The influence of P-glycoprotein on morphine transport in Caco-2 cells. Comparison with paclitaxel. Eur J Pharmacol 440:7-16. (Pubitemid 34312033)
    • (2002) European Journal of Pharmacology , vol.440 , Issue.1 , pp. 7-16
    • Crowe, A.1
  • 49
    • 0034874453 scopus 로고    scopus 로고
    • Effect of mdr1a p-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds
    • DOI 10.1023/A:1010984110732
    • Dagenais C, Zong J, Ducharme J, Pollack GM. 2001. Effect of mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds. Pharm Res 18:957-963. (Pubitemid 32799940)
    • (2001) Pharmaceutical Research , vol.18 , Issue.7 , pp. 957-963
    • Dagenais, C.1    Zong, J.2    Ducharme, J.3    Pollack, G.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.